Cima Sciences was proud to present new data via two posters at The Liver Meeting 2024 organized by the AASLD. It is our mission to continue our legacy of clinical research driving better characterization and therapeutic monitoring of MASLD.

Poster of Distinction: Evaluation of the Performance of MASEF Score in Patients with Metabolic Dysfunction Associated Steatohepatitis (MASH) Under a Lipid-Lowering Medication

Poster #2: Evaluation of Two Non-Invasive Approaches to Assessing At-Risk MASH in Clinical Practice: MASEF and FAST Scores

Please contact us to discuss these findings and discuss future clinical research programs.